UJ

Udo Jahannes Vetter

Active Director Director DIN 00707474
DIN 00707474 First appointment May 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since May 2008
Shareholding value •••• Premium profile

About Udo Jahannes Vetter

Data last updated:

Udo Jahannes Vetter is a Director at Gland Pharma Ltd (since 2018) and Director at Paschal Form Work (India) Private Limited (since 2008). The companies operate in Healthcare and Manufacturing. The 2 current companies with reported revenue have a combined latest revenue of ₹6,760 Cr; the largest is Gland Pharma Ltd at ₹6,747 Cr (FY 2026). Earlier, Udo Jahannes Vetter was a Director at Paschal Technology (India) Private Limited (from 2008).

DIN 00707474
Primary Designation Director
Industry Healthcare
First Appointment 02 May 2008
Oldest Company Age 48 yrs
Largest company Gland Pharma Ltd · ₹6,747 Cr (FY 2026)
Combined revenue ₹6,760 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gland Pharma Ltd L24239TG1978PLC002276
Director07 Feb 20181978₹6,747 Cr (FY 2026)Active
Director02 May 20082008₹12.88 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 May 20082008Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Udo Jahannes Vetter

NameDINCompanyDesignation
Essaji Goolam Vahanvati00157299Gland Pharma LtdDirector
Jia Ai Zhang09170927Gland Pharma LtdDirector
Naina Lal Kidwai00017806Gland Pharma LtdDirector
Ravi Shekhar MitraGland Pharma LtdCfo
Sampath Kumar PallerlamudiGland Pharma LtdCompany Secretary
Srinivas Sadu06900659Gland Pharma LtdWhole-Time Director
Wei Huang10818586Gland Pharma LtdDirector
William Robert Keller11593622Gland Pharma LtdDirector
Xingli Wang11899926Gland Pharma LtdAdditional Director
Barbara Regina Geb Maier Vetter01898461Paschal Form Work (India) Private LimitedDirector
Keerthi JainPaschal Form Work (India) Private LimitedCompany Secretary
Radhakrishna Vegesana01483148Paschal Form Work (India) Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gland Pharma Ltd
Paschal Form Work (India) Private Limited
Paschal Technology (India) Private Limited
Premium access

Shareholding and investment profile for Udo Jahannes Vetter

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Udo Jahannes Vetter

Udo Jahannes Vetter currently holds 2 directorships: Gland Pharma Ltd (Director, since 07 Feb 2018, revenue ₹6,747 Cr (FY 2026)); Paschal Form Work (India) Private Limited (Director, since 02 May 2008, revenue ₹12.88 Cr (FY 2025)).

Udo Jahannes Vetter was first appointed on 02 May 2008 as Director at Paschal Form Work (India) Private Limited. The most recent appointment on record is 07 Feb 2018 at Gland Pharma Ltd.

The 2 current companies of Udo Jahannes Vetter that report revenue have a combined latest revenue of ₹6,760 Cr: Gland Pharma Ltd ₹6,747 Cr (FY 2026); Paschal Form Work (India) Private Limited ₹12.88 Cr (FY 2025).

Udo Jahannes Vetter held 1 earlier board appointment: Paschal Technology (India) Private Limited (Director, from 02 May 2008).

The current boards of Udo Jahannes Vetter's companies include Essaji Goolam Vahanvati (Gland Pharma Ltd), Jia Ai Zhang (Gland Pharma Ltd), Naina Lal Kidwai (Gland Pharma Ltd), Ravi Shekhar Mitra (Gland Pharma Ltd), Sampath Kumar Pallerlamudi (Gland Pharma Ltd), Srinivas Sadu (Gland Pharma Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available